Loading clinical trials...
Loading clinical trials...
Phase III Randomized Multicenter International Study to Investigate the Safety and Efficacy of Propionyl-L-Carnitine Hydrochloride Modified Release Tablets in Patients Affected by Mild Ulcerative Colitis Under Oral Stable Treatment
Conditions
Interventions
Propionyl-L-Carnitine
Placebo
Locations
58
Austria
Landeskrankenhaus-Universitätskliniken Innsbruck - Klinische Abteilung für Gastroenterologie und Hepatologie
Innsbruck, Austria
Krankenhaus der Barmherzigen Brüder - Abteilung für Innere Medizin
Salzburg, Austria
Allgemeines Krankenhaus Wien - Universitätsklinik Klinik für Innere Medizin III
Vienna, Austria
Ordinationszentrum Döbling
Vienna, Austria
Centre Hospitalier Intercommunal Créteil 40 avenue de Verdun
Créteil, France
Centre Hospitalier Universitaire Hôpital Nord - Service D'Hépato-Gastro-Entérologie
Marseille, France
Start Date
April 1, 2012
Primary Completion Date
October 1, 2013
Completion Date
January 1, 2014
Last Updated
November 7, 2016
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
sigma-tau i.f.r. S.p.A.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions